Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Myelodysplastic Syndromes 14Multiple Myeloma 8Leukemia 8Hematologic Neoplasms 8Lymphoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Graft vs Host Disease 7Lymphoma, Non-Hodgkin 6Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Primary Myelofibrosis 4Neoplasms, Plasma Cell 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Myeloproliferative Disorders 3Burkitt Lymphoma 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Prolymphocytic 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Biphenotypic, Acute 2Congenital Abnormalities 2

Interventions

Cyclophosphamide 12Etoposide 11Granulocyte Colony-Stimulating Factor 7Filgrastim 7Carboplatin 7etoposide phosphate 6Vincristine 5Methotrexate 5Cisplatin 5fludarabine 4Topotecan 4Thiotepa 4Stem Cell Transplantation 4Radiotherapy 4Mesna 4Melphalan 4Temozolomide 3Sirolimus 3Ifosfamide 3Busulfan 3Automobiles 3selinexor 2sargramostim 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Leucovorin 2Ipilimumab 2Hydrocortisone 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Rhabdoid Tumor × Hematopoietic Stem Cell Transplantation × Clear all
NCT04521946 2024-10-26

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

M.D. Anderson Cancer Center

Phase 1 Withdrawn
CNS

Choroid Plexus Carcinoma, Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡